 DUBLIN, Ireland and CHICAGO, Sept. 08, 2021 GLOBE NEWSWIRE -- Iterum Therapeutics plc Nasdaq: ITRM the Company, a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that Corey Fishman, Chief Executive Officer, will provide a company overview and business update at the H.C. Wainwright 23rd Annual Virtual Global Investment Conference. The presentation will be available on-demand starting Monday, September 13, at 7:00 A.M. ET. The webcasting link is 